Abstract
A nickel-catalyzed oxidative decarboxylative annulation reaction of simple benzamides and (hetero)aromatic carboxylates has been developed. This reaction provides access to a large array of phenanthridinones and their heterocyclic analogues, highlighting the utility and versatility of oxidative decarboxylative coupling strategies for C-C bond formation.
Graphical abstract

Phenanthridinones are key structures found in a variety of natural products and biologically active compounds1 including antiviral and anticancer therapeutics2, aurora kinase3 and polymerase (PARP) inhibitors4 as well as serve as important building blocks toward complex polycyclic targets.5 The corresponding heterocycle-containing phenanthridinones, however, are less-explored due, in part, to a shortage of efficient synthetic routes to these compounds. Because of the prevalence of heterocycles with important biological properties,6 the ability to access such heterocycle-containing phenanthridinones could provide new libraries of compounds with novel properties and activities.
Typically, construction of these scaffolds7,8 relies on traditional cross-coupling reactions,3 such as Suzuki-Miyaura coupling (Scheme 1, eq 1) or Buchwald-Hartwig amination reactions.9 These methods, however, require prefunctionalized aryl halide and arylboronic ester or acid coupling partners. Alternatively, oxidative C-H arylation routes enable the utilization of simple arenes as coupling partners,10 yet we are aware of only a single report in which efficient incorporation of heteroarenes into phenanthridinone structures is achieved (Scheme 1, eq 2). 10f Baidya and coworkers have reported the copper-mediated dehydrogenative annulation of amides with fluorinated arenes in which 3,5-difluoropyridine is also a competent coupling partner (Scheme 1, eq 2).
Scheme 1.

Selected Examples of Synthetic Routes to Phenanthridinones.
More recently, transition-metal catalyzed oxidative decarboxylative coupling (ODC) reactions11 have been applied to the synthesis of phenanthridinones. Wang and coworkers reported the synthesis of phenanthridinones utilizing a Pd-catalyzed ODC strategy to effect the coupling of aryl acyl peroxides in fair yields.12 Similarly, Miura13 and coworkers reported an analogous copper-mediated ODC reaction for the synthesis of phenanthridinones from ortho-nitrobenzoates (Scheme 1, eq 3) Unfortunately, both catalyst systems are limited to select benzoic acids, and heteroaryl carboxylates are ineffective coupling partners under these reported conditions. We have recently developed a new nickel catalyst system for the efficient ODC reactions of a large scope of heteroaryl carboxylates.14 In this work, we highlight the utility of a related nickel-catalyzed oxidative decarboxylative annulation strategy for the synthesis of heterocycle-containing phenanthridinones (Scheme 1, eq 4).
During the course of our previous studies, we observed the formation of the oxidative decarboxylative annulation product 3 in low yields when ortho-fluoro substituted (hetero)aromatic carboxylates 2 were employed as coupling partners. Following this initial discovery, we focused our attention on optimizing the conditions for the coupling of quinolinylbenzamide 1a15 with the 2-fluoronicotinic carboxylate 2a (Table 1). Ni(OAc)2 4H2O was identified to be the most efficient precatalyst generating 3a in 25% yield (Table 1, entry 4), while all other Ni salts tested provided only low yields of the product (<10%, Table S1). Replacing Ag2CO3 with AgNO3 was found to dramatically increase the yield of 3a to 72% (Table 1, entry 8). Finally, increasing the loading of 2a to 2 equivalents led to an increase in yield of 3a to 81% (Table 1, entry 9). No coupled product 3a was observed when either nickel or silver was omitted from the reaction (entries 10 and 11, respectively). Therefore, the optimized reaction conditions employ 20 mol % Ni(OAc)2 4H2O, AgNO3 (4.0 equivalents), and Na2CO3 (4.0 equivalents) in DMA at 130 °C for 24 h.
Table 1. Optimization of Reaction Conditionsa.
![]() | |||
|---|---|---|---|
| entry | [Ni] | oxidantb | yield 3a (%)c |
| 1 | Ni(acac)2 | Ag2CO3 | 4 |
| 2 | Ni(OTf)2 | Ag2CO3 | 3 |
| 3 | NiCl2 | Ag2CO3 | 5 |
| 4 | Ni(OAc)2·4H2O | Ag2CO3 | 25 |
| 5 | Ni(OAc)2·4H2O | AgOPiv | 63 |
| 6 | Ni(OAc)2·4H2O | AgOAc | 51 |
| 7 | Ni(OAc)2·4H2O | Ag3PO4 | 35 |
| 8 | Ni(OAc)2·4H2O | AgNO3 | 72 |
| 9d | Ni(OAc)2·4H2O | AgNO3 | 81 (80)e |
| 10d | — | AgNO3 | 0 |
| 11d | Ni(OAc)2·4H2O | — | 0 |
Reaction conditions: 1a (0.2 mmol), 2a (0.3 mmol) in DMA (2 mL). Q = quinolyl
4.0 equiv Ag was used in all reactions (0.4 mmol Ag2CO3, 0.8 mmol AgOPiv and AgNO3, and 0.26 mmol. Ag3PO4).
1H NMR yield with 1,3,5-trimethoxybenzene as an internal standard.
2a (0.4 mmol).
Isolated yield.
With the optimized reaction conditions in hand, we turned our attention to the heteroaromatic carboxylate coupling partners (Scheme 2). The reaction is compatible with both electron-withdrawing (2d, 2e, 2g) and electron-donating (2b, 2c, 2f) substituents on the nicotinic carboxylate. Substitution in the 6-position (2c-2e) resulted in slightly lower yields than that obtained with the parent (2a) nicotinate, while substitution in the 5-position was better-tolerated (2f and 2g). This reaction system also tolerates bromo-and chloro-substitution allowing for further functionalization of the cyclized products 3e and 3g. We focused our attention on halide-substituted 2-fluoronicotinic carboxylates because they are the most accessible from existing synthetic routes.16 Quinoline and thiophene scaffolds are found in pharmacologically active compounds17 and material sciences18 and the corresponding carboxylates 2h-2j also proved to be competent coupling partners under these catalytic conditions. Finally, this protocol could also be conducted on a 1 mmol scale without a significant reduction in yield (75% of 3a).
Scheme 2. Scope of Heteroaromatic Carboxylate Coupling Partners in the Ni-Catalyzed Oxidative Decarboxylative Annulation Reaction.a.

aIsolated yields. Reaction conditions: 1a (0.2 mmol), 2 (0.4 mmol) in DMA (2 mL). Q =quinolyl. b130 °C for 8 h then 170 °C for 16 h c170 °C.
We then examined the scope of the substituted benzoate coupling partners (Scheme 3). The decarboxylative annulation of ortho-fluorobenzoates proceeded smoothly at 170 °C when a variety of electron-donating (2m, 2n) and electron-withdrawing substituents (2l, 2o, 2p) were included. Unfortunately, the di-ortho-substituted benzoate 2q was an ineffective coupling partner under these reaction conditions (Chart S1).
Scheme 3. Scope of Benzoate Coupling Partners in the Ni-Catalyzed Oxidative Decarboxylative Annulation Reaction.a.

aIsolated yields. Reaction conditions: 1a (0.2 mmol), 2 (0.4 mmol) in DMA (2 mL). Q = quinolyl.
Finally, we explored the scope of substituted benzamide coupling partners (Scheme 4). Although other directing groups have proven valuable in related catalytic coupling reactions,19 this decarboxylative annulation reaction appears to be limited to the 8-aminoquinoline directing group (Chart S1), which can be removed under oxidizing conditions.20 Substrates with electron-donating groups para to the benzamide functionality (1r, 1s) afforded higher yields (75% and 71%, respectively) than those bearing electron-withdrawing groups (1t, 63%). Similarly, substrates with electron-donating groups in the meta-position (1u, 1v) provided higher yields (70% and 54% respectively) than those with electron-withdrawing functionalities (1w, 31% yield). It should be mentioned that the absence of ortho-substitution resulted in a lower yield (1x, 48%). This new catalyst system also tolerates heterocyclic benzamide 1y providing the opportunity to access additional classes of substituted phenanthridinones with this methodology.
Scheme 4. Scope of Benzamide Coupling Partners in the Ni-Catalyzed Oxidative Decarboxylative Annulation Reaction.a.

aIsolated yields. Reaction conditions: 1 (0.2 mmol), 2a (0.4 mmol) in DMA (2 mL). Q =quinolyl.
We hypothesized that this new decarboxylative annulation reaction likely proceeds via an initial oxidative decarboxylative heteroarylation step,14 followed by an SNAr-type ring closing reaction10f,13,21 (Scheme 5). To explore the possibility of such a pathway, we conducted a series of control experiments. First, we performed the standard reaction in the presence of common radical trapping reagents. The reaction of 1a and 2a in the presence of 1.0 equivalent of TEMPO or 9,10-dihydroanthracence resulted in only a slight decrease in the yields (74 and 78% respectively, Table S6) These data are consistent with the absence of trappable radical intermediates.22
Scheme 5. Proposed Pathway for the Ni-Catalyzed Oxidative Decarboxylative Annulation Reaction.a.

aQ = quinolyl.
Next, to gain insight into the C-H activation step, we carried out a pair of deuterium-exchange and kinetic isotope effect (KIE) experiments (Scheme 6). First, we measured the KIE from an intermolecular competition experiment. The reaction of an equimolar mixture of 1a and 1a-d7 was treated under the standard reaction conditions. After 30 min, the product was obtained as a mixture of 3a and 3a-d6 in 16% and 4% yields, respectively, giving a KIE of 4.5. We then carried out a hydrogen-deuterium exchange experiment of the deuterated benzamide 1a-d7. When the standard reaction is conducted with 1a-d7 for 30 min, less than 1% H incorporation is observed. These combined data suggest that the cleavage of the C-H bond is an irreversible process, similar to that observed in our prior studies of the Ni-catalyzed ODC reaction.14
Scheme 6. Kinetic Isotope Effect in the Ni-Catalyzed Oxidative Decarboxylative Annulation Reaction.a.

aQ = quinolyl.
Finally, we explored the C-N bond-forming step. Treatment of independently synthesized fluorinated biaryl benzamide 1z with 4.0 equivalents of sodium carbonate in the absence of both silver and nickel resulted in the formation of the cyclized product 3k in nearly quantitative yield (>95%, Scheme 7). Taken together, these data are consistent with a pathway involving initial Ni-catalyzed oxidative decarboxylative arylation followed by a based-promoted ring closing reaction as proposed in Scheme 5.
Scheme 7. Base-Promoted SNAr-Type Cyclization.a.

aQ = quinolyl.
In conclusion, we have developed the first nickel-catalyzed oxidative decarboxylative annulation reaction for the synthesis of heterocycle-containing phenanthridinones. This new method is effective not only for the coupling of heteroaromatic carboxylates but also for that of ortho-fluorobenzoates. As a result, this reaction allows access to a series of new heterocycle-containing phenanthridinones of potential biological importance.
Supplementary Material
ACKNOWLEDGMENT
We are grateful to the NSF (CHE-1453879), the NIH (1R15GM126514–01) and West Virginia University for financial support of this work. NMR spectroscopy facilities were partially supported by the NSF (CHE-1228336).
Footnotes
ASSOCIATED CONTENT
Supporting Information
The Supporting Information is available free of charge on the ACS Publications website.
Experimental procedures and characterization data for starting materials and products (PDF)
Th authors declare no competing financial interest.
REFERENCES
- (1).(a) Curtin NJ; Szabo C Mol. Aspects. Chem. 2013, 34, 1217–1256. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Mishra S; De S; Kakde BN; Dey D; Bisai A Indian J. Chem. A 2013, 52, 1093–1102. [Google Scholar]
- (2).(a) Grese TA, Adrian MD, Phillips DL, Shetler PK, Short LL, Glasebrook AL, Bryant HU, J. Med. Chem. 2001, 44, 2857–2860. [DOI] [PubMed] [Google Scholar]; (b) Yaragorla S; Pareek A; Dada R Adv. Synth. Catal. 2017, 359, 3068–3075. [Google Scholar]; (c) Hesse M In: Wallimann PM, Kisakurek MV, eds. Alkaloids Nature’s Curse or Blessing? Zurich: Wiley-VCH; 2002. [Google Scholar]
- (3).(a) Kuwata Y; Sonoda M; Tanimori SJ Heterocycl. Chem. 2017. 54, 1645–1651. [Google Scholar]; (b) Karra S; Xiao Y; Chen X; Liu-Bujalski L; Huck B; Sutton A; Goutopoulos A; Askew B; Jose-phson K; Jiang X; Shutes A; Shankar V; Noonan T; Garcia-Berrios G; Dong R; Dhanabal M; Tian H; Wang Z; Clark A; Goodstal S Bioorg. Med. Chem. Lett. 2013, 23, 3081–3087. [DOI] [PubMed] [Google Scholar]; (c) Huck BR; Chen X; Deselm LC; Jones CCV; Karra SR; Xiao Y; Goutopoulos A; Sutton AE Protein Kinase Inhibitors and Use Thereof U.S. Pat. Appl. Publ, 20110053906 March 3, 2011 [Google Scholar]; (d) Ferraccioli R; Carenzi D; Rombola O; Catellani M Org. Lett. 2004, 6, 4759–4762. [DOI] [PubMed] [Google Scholar]
- (4).Weltin D; Holl V; Hyun JW; Dufour P; Marchal J; Bischoff P Int. J. Radiat. Biol. 1997, 72, 685–692. [DOI] [PubMed] [Google Scholar]
- (5).(a) Nealmongkol P; Calmes J; Ruchirawat S; Thasana N Tetrahedron. 2017, 73, 735–741. [Google Scholar]; (b) Dubrovskiy AV; Markina NA; Larock RC Org. Biomol. Chem. 2013, 11, 191–218. [DOI] [PubMed] [Google Scholar]; (c) Basolo L; Beccalli EM; Borsini E; Broggini G Tetrahedron. 2009, 65, 3486–3491. [Google Scholar]; (d) Rajeshkumar V; Lee T-H; Chuang S-C Org. Lett. 2013, 15, 1468–1471. [DOI] [PubMed] [Google Scholar]; (e) Chen Y-F; Wu Y-S; Jhan Y-H; Hsieh J-C Org. Chem. Front. 2014, 1, 253–257. [Google Scholar]
- (6).Roughley SD; Jordan AMJ Med.. Chem. 2011, 54, 3451–3479. [DOI] [PubMed] [Google Scholar]
- (7).(a) Rafiee F Appl. Organometal. Chem. 2017, 31, e3820. [Google Scholar]; (b) Fresneau N; Cailly T; Fabis F; Bouillon J-P Tetrahedron 2013, 69, 5393–5400. [Google Scholar]; (c) Fang Y; Tranmer GK Med. Chem. Commun. 2016, 7, 720–724. [Google Scholar]; (d) Wang S; Shao P; Du G; Xi C J. Org. Chem. 2016, 81, 6672–6676. [DOI] [PubMed] [Google Scholar]
- (8).(a) Liang D; Hu Z; Peng J; Huang J; Zhu Q Chem. Commun. 2013, 49, 173–175. [DOI] [PubMed] [Google Scholar]; (b) Shi R; Niu H; Lu L; Lei A Chem. Commun. 2017, 53, 1908–1911. [DOI] [PubMed] [Google Scholar]
- (9).Hirata T; Isao T; Suzuki Y; Yoshida H; Hasegawa H; Kitagawa OJ Org. Chem. 2016, 81, 318–323. [DOI] [PubMed] [Google Scholar]
- (10).(a) Yedage SL; Bhanage BM J. Org. Chem. 2016. 81, 4103–4111. [DOI] [PubMed] [Google Scholar]; (b) Karthikeyan J; Cheng C-C Angew. Chem. 2011, 123, 10054–10057. [Google Scholar]; (c) Wang G-W; Yuan T-T; Li D-D Angew. Chem 2011, 123, 1416–1419. [Google Scholar]; (d) Karthikeyan J; Haridharan R; Cheng C-C Angew. Chem. Int. Ed. 2012, 51, 12343–12347. [DOI] [PubMed] [Google Scholar]; (e) Zhang T-Y; Lin J-B; Li Q-Z; Kang J-C; Pan J-L, Hou S-H; Chen C; Zhang S-Y Org. Lett. 2017, 19, 1764–1767. [DOI] [PubMed] [Google Scholar]; (f) Mandal A; Selvakumar J; Dana S; Mukherjee U; Baidya M Chem. Eur. J. 2018, 24, 3448–3454. [DOI] [PubMed] [Google Scholar]
- (11).(a) Wei Y; Hu P; Zhang M; Su W Chem. Rev. 2017, 117, 8864–8907. [DOI] [PubMed] [Google Scholar]; (b) Perry GJP; Larrosa I Eur. J. Org. Chem. 2017, 3517–3527. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Chen L; Ju L; Bustin KA; Hoover JM Chem. Commun. 2015, 51, 15059–15062. [DOI] [PubMed] [Google Scholar]; (d) Patra T; Nandi S; Sahoo SK; Maiti D Chem. Commun. 2016, 52, 1432–1435. [DOI] [PubMed] [Google Scholar]; (e) Li Yanrong, Qian F; Wang M; Lu H; Li G Org. Lett. 2017, 19, 5589–5592. [DOI] [PubMed] [Google Scholar]; (f) Zhao S; Liu Y-J; Yan S-Y; Chen F-J; Zhang Z-Z; Shi B-F Org. Lett. 2015, 17, 3338–3341. [DOI] [PubMed] [Google Scholar]
- (12).Li D; Xu N; Zhang Y; Wang L Chem. Commun. 2014, 50, 14862–14865. [DOI] [PubMed] [Google Scholar]
- (13).Takamatsu K; Hirano K; Miura M Angew. Chem. Int. Ed. 2017, 56, 5353–5357. [DOI] [PubMed] [Google Scholar]
- (14).Honeycutt AP; Hoover JM ACS Catal. 2017, 7, 4597–4601. [Google Scholar]
- (15).(a) Zaitsev VG; Shabashov D; Daugulis O J. Am. Chem. Soc. 2005, 127, 13154–13155. [DOI] [PubMed] [Google Scholar]; (b) Shabashov D; Daugulis OJ Am. Chem. Soc. 2010, 132, 3965–3972. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Cheng Y; Wu Y; Tan G; You J Angew. Chem Int. Ed 2016, 55, 12275–12279. [DOI] [PubMed] [Google Scholar]
- (16).(a) Fier PS; Hartwig JF Science 2013, 342, 956–960. [DOI] [PubMed] [Google Scholar]; (b) Taylor EC; Zhou P Org. Prep. Proced. Int. 1997, 29, 221–223. [Google Scholar]; (c) Yerien DE; Bonesi S; Postigo A Org. Biomol. Chem. 2016, 14, 8398–8427. [DOI] [PubMed] [Google Scholar]; (d) Schimler SD; Ryan SJ; Bland DC; Anderson JE; Sanford MS J. Org. Chem. 2015, 80, 12137–12145. [DOI] [PubMed] [Google Scholar]
- (17).Li L; Mathieu M-C; Denis D; Therien AG; Wang Z Bioorg. Med. Chem. Lett. 2011, 21, 734–737. [DOI] [PubMed] [Google Scholar]
- (18).Kovarova A; Svoboda J; Novotna V; Glogavora M; Salamonczyk M; Pociecha D; Gorecka E Liq. Cryst. 2010, 37, 1501–1513. [Google Scholar]
- (19).Sambiagio C; Schönbauer D; Blieck R; Dao-Huy T; Pototschnig G; Schaaf P; Wiesinger T; Zia MF; Wencel-Delord J; Besset T; Maes BUW; Schnürch M Chem. Soc. Rev. 2018, 47, 6603–6743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (20).Berger M; Chauhan R; Rodrigues CAB; Maulide N Chem. Eur. J. 2016, 22, 16805–16808. [DOI] [PubMed] [Google Scholar]
- (21).(a) Travieso-Puente R; Budzak S; Chen J; Stacko P; Jastrzebski JTBH; Jacquemin D; Otten EJ Am. Chem. Soc. 2017, 139, 3328–3331. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Kwan EE; Zeng Y; Besser HA; Jacobsen EN Nat. Chem. 2018, 10, 917–923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (22).(a) Moon Y; Jang E; Choi S; Hong S Org. Lett. 2018, 20, 240–243. [DOI] [PubMed] [Google Scholar]; (b) Bhakuni BS; Kumar A; Balkrishna SJ; Sheikh JA; Konar S; Kumar S Org. Lett. 2012, 14, 2838–2841. [DOI] [PubMed] [Google Scholar]; (c) Yuan M; Chen L; Wang J; Chen S; Wang K; Xue Y; Yao G; Luo Z; Zhang Y Org. Lett. 2015, 17, 346–349. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

